IRF4 and lymphoid neoplasm: Genetic knockdown of IRF4 or treatment with IRF4-degrading immunomodulatory drugs (e.g., lenalidomide or pomalidomide) hinders cell proliferation and induces apoptosis in various lymphoid neoplasms in vitro [57,58,59,67,68,82,90,91,92,93].